Pais G, Chang J, Barreto E, Stitt G, Downes K, Alshaer M
Clin Pharmacokinet. 2022; 61(7):929-953.
PMID: 35764774
PMC: 9345683.
DOI: 10.1007/s40262-022-01137-y.
Farkas A, Oikonomou K, Ghanbar M, Villasurda P, Varghese J, Lipman J
Antimicrob Agents Chemother. 2021; 66(2):e0167921.
PMID: 34902267
PMC: 8846465.
DOI: 10.1128/AAC.01679-21.
Darlow C, da Costa R, Ellis S, Franceschi F, Sharland M, Piddock L
Paediatr Drugs. 2021; 23(5):465-484.
PMID: 34435316
PMC: 8418595.
DOI: 10.1007/s40272-021-00465-z.
Li Y, Xie M, Zhou J, Lin H, Xiao T, Wu L
Front Microbiol. 2020; 11:511356.
PMID: 33072002
PMC: 7536268.
DOI: 10.3389/fmicb.2020.511356.
Frank M, Yao J, Batte J, Gullett J, Subramanian C, Rosch J
mBio. 2020; 11(3).
PMID: 32430471
PMC: 7240157.
DOI: 10.1128/mBio.00920-20.
Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus.
Oh J, Cassino C, Schuch R
Antimicrob Agents Chemother. 2019; 63(6).
PMID: 30936103
PMC: 6535547.
DOI: 10.1128/AAC.02616-18.
Synergistic Antimicrobial Activity of Colistin in Combination with Rifampin and Azithromycin against Escherichia coli Producing MCR-1.
Li Y, Lin X, Yao X, Huang Y, Liu W, Ma T
Antimicrob Agents Chemother. 2018; 62(12).
PMID: 30224527
PMC: 6256761.
DOI: 10.1128/AAC.01631-18.
Extended Interval Tobramycin Pharmacokinetics in a Pediatric Patient With Primary Ciliary Dyskinesia Presenting With an Acute Respiratory Exacerbation.
Higgins K, Noda C, Stultz J
J Pediatr Pharmacol Ther. 2018; 23(2):159-163.
PMID: 29720919
PMC: 5916445.
DOI: 10.5863/1551-6776-23.2.159.
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.
Onufrak N, Forrest A, Gonzalez D
Clin Ther. 2016; 38(9):1930-47.
PMID: 27449411
PMC: 5039113.
DOI: 10.1016/j.clinthera.2016.06.015.
CD101: a novel long-acting echinocandin.
Zhao Y, Perez W, Jimenez-Ortigosa C, Hough G, Locke J, Ong V
Cell Microbiol. 2016; 18(9):1308-16.
PMID: 27354115
PMC: 5096055.
DOI: 10.1111/cmi.12640.
In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes.
Guo C, Liao X, Wang M, Wang F, Yan C, Xiao X
Antimicrob Agents Chemother. 2015; 60(2):1114-20.
PMID: 26666923
PMC: 4750656.
DOI: 10.1128/AAC.02065-15.
Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice.
Lepak A, Marchillo K, VanHecker J, Azie N, Andes D
Antimicrob Agents Chemother. 2015; 60(1):674-7.
PMID: 26552968
PMC: 4704180.
DOI: 10.1128/AAC.02124-15.
Antifungal pharmacokinetics and pharmacodynamics.
Lepak A, Andes D
Cold Spring Harb Perspect Med. 2014; 5(5):a019653.
PMID: 25384765
PMC: 4448584.
DOI: 10.1101/cshperspect.a019653.
Evaluation of a Once-Daily Vancomycin Regimen in an Outpatient Leukemia/Bone Marrow Transplant Clinic (OD-VANCO Study).
Luo C, Hussaini T, Lacaria K, Yeung J, Lau T, Broady R
Can J Hosp Pharm. 2014; 67(4):280-5.
PMID: 25214659
PMC: 4152967.
DOI: 10.4212/cjhp.v67i4.1372.
In vivo activity of cefquinome against Escherichia coli in the thighs of neutropenic mice.
Shan Q, Liang C, Wang J, Li J, Zeng Z
Antimicrob Agents Chemother. 2014; 58(10):5943-6.
PMID: 25070101
PMC: 4187953.
DOI: 10.1128/AAC.03446-14.
Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.
Wang J, Shan Q, Ding H, Liang C, Zeng Z
Antimicrob Agents Chemother. 2014; 58(6):3008-12.
PMID: 24614373
PMC: 4068449.
DOI: 10.1128/AAC.01666-13.
Post-β-lactamase-inhibitor effect of tazobactam in combination with ceftolozane on extended-spectrum-β-lactamase-producing strains.
Sader H, Rhomberg P, Jones R
Antimicrob Agents Chemother. 2014; 58(4):2434-7.
PMID: 24449780
PMC: 4023764.
DOI: 10.1128/AAC.02398-13.
Evaluation of serum concentrations achieved with an empiric once-daily tobramycin dosage regimen in children and adults with cystic fibrosis.
Vandenbussche H, Homnick D
J Pediatr Pharmacol Ther. 2012; 17(1):67-77.
PMID: 23118659
PMC: 3428189.
DOI: 10.5863/1551-6776-17.1.67.
Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).
Varghese J, Roberts J, Wallis S, Boots R, Healy H, Fassett R
Clin J Am Soc Nephrol. 2012; 7(8):1249-56.
PMID: 22700884
PMC: 3408127.
DOI: 10.2215/CJN.12211211.
Mathematical model of plasmid-mediated resistance to ceftiofur in commensal enteric Escherichia coli of cattle.
Volkova V, Lanzas C, Lu Z, Grohn Y
PLoS One. 2012; 7(5):e36738.
PMID: 22615803
PMC: 3353932.
DOI: 10.1371/journal.pone.0036738.